The Missing Link between (Un)druggable and Degradable KRAS
Main Authors: | Elena De Vita, Maria Maneiro, Edward W. Tate |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2020-08-01
|
Series: | ACS Central Science |
Online Access: | https://doi.org/10.1021/acscentsci.0c00920 |
Similar Items
-
KRAS mutation: from undruggable to druggable in cancer
by: Lamei Huang, et al.
Published: (2021-11-01) -
KRAS: A Druggable Target in Colon Cancer Patients
by: Francesca Negri, et al.
Published: (2022-04-01) -
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
by: Elisa Baldelli, et al.
Published: (2021-09-01) -
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
by: Chunxiao Zhu, et al.
Published: (2022-08-01) -
Seizures are a druggable mechanistic link between TBI and subsequent tauopathy
by: Hadeel Alyenbaawi, et al.
Published: (2021-02-01)